SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales for the September 2023 quarter moved down to Rs. 2246.21 millions as compared to Rs. 2784.02 millions during the year-ago period.The Net proft of the company remain more or less same to Rs. 747.26  millions from Rs. 789.22 millions ,decline by -5.32%.The Operating Profit of the company witnessed a decrease to 1115.55 millions from 1170.32 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 2246.21 2784.02 -19.32 5686.47 6172.01 -7.87 13300.80 13202.22 0.75
Other Income 142.00 103.89 36.68 242.59 212.87 13.96 445.52 1877.88 -76.28
PBIDT 1115.55 1170.32 -4.68 2914.96 2826.69 3.12 6276.30 7677.76 -18.25
Interest 5.03 2.90 73.45 16.50 17.23 -4.24 53.92 62.31 -13.46
PBDT 1110.52 1167.42 -4.87 2898.46 2809.46 3.17 6222.38 7615.45 -18.29
Depreciation 104.81 107.56 -2.56 216.29 213.04 1.53 428.45 390.97 9.59
PBT 1005.71 1059.86 -5.11 2682.17 2596.42 3.30 5793.93 7224.48 -19.80
TAX 258.45 270.64 -4.50 691.98 666.69 3.79 1467.91 1643.49 -10.68
Deferred Tax 15.52 14.39 7.85 35.94 21.63 66.16 43.38 67.19 -35.44
PAT 747.26 789.22 -5.32 1990.19 1929.73 3.13 4326.02 5580.99 -22.49
Equity 254.57 254.57 0.00 254.57 254.57 0.00 254.57 254.57 0.00
PBIDTM(%) 49.66 42.04 18.14 51.26 45.80 11.93 47.19 58.16 -18.86

Cohance Lifesciences Share Price

478.65 -9.65 (-1.98%)
11-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1872.40
Dr. Reddys Lab 1279.70
Cipla 1304.70
Zydus Lifesciences 956.65
Lupin 2245.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×